Clinical and Molecular Hepatology · 6 Nov 2026
SGLT2 inhibitor and fibrosis progression in MASLD: Correspondence to letter to the editor on “Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis”
Jonggi Choi, Raymond T. Chungh-index 13
0
Citations
no database records one yet
0
Citations in 2026
so far
13
Leading author's h-index
Raymond T. Chung, in QAI's scholar index
0
References
works it cites, from open citation data
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
No abstract is available for this paper.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Raymond T. Chung has the highest h-index among the authors (13).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
0 shown
No citing papers for this filter.
References (0)
What it cites, from open citation data, with Crossref's record of each.
No references in the open citation data yet.